| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Rapid Therapeutic Science Laboratories, Inc. (RTSL) has 0 insiders with recent SEC Form 4 filings, including 0 buys and 6 sells. RTSL is classified in the Diversified Financial Services industry within the Financials sector.
| Role | Insider | Shares | Value | 30d |
|---|
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 28, 2020 | Berrier Sean Paul | 10% Owner | Sell | 4,266,667 | $0.27 | $1,150,000.10 | -2.7% | |
| Dec 28, 2020 | Schmidt Donal Ray Jr. | President And CEO | Sell | 4,266,667 | $0.27 | $1,150,000.10 | -2.7% |